Research may lead to new therapies for vascular disorders

September 13, 2013

Auckland scientists have contributed to identifying a novel genetic pathway used in the stabilisation of blood vessels.

These discoveries may open up a new approach in the development of therapies to treat .

After five years collaboration with the San Francisco-based company, Genentech, (owned by successful pharmaceutical corporation, Roche), a research team from the University of Auckland have just published a paper on the work, in Blood, the journal of the American Society for Hematology. It is considered the leading journal for reporting basic and applied haematology research.

"This has been a significant and productive collaboration for our group," says Professor Phil Crosier who leads this work in the University's Department of Molecular Medicine and Pathology. "It has been fantastic from our perspective, dealing with these talented and committed scientists from Genentech, and the culmination of this work being published in the journal Blood."

"The paper used a range of different scientific research models, where we contributed the zebrafish discoveries," says Professor Crosier. "The success of this collaboration lies in the intellectual input and high quality innovative real time work undertaken by Dr Chris Hall, a Senior Research Fellow in our group."

"The original research question was looking at whether we can use zebrafish genetics to identify targets that we might be able to develop drugs around", says Dr Hall. That turned out to be one aspect of a much wider collaboration.

"Dr. Crosier's group carried out thorough in vivo functional analyses in zebrafish of many genes that we identified. We have high regard for their scientific rigor and expertise and are very impressed by the exquisite quality of their data", says Dr. Weilan Ye, the lead scientist of this project at Genentech.

"It has been richly rewarding for us, especially the way they value our expertise, paying tribute to both the quality and the precision of the work done, and the data in the final paper," says Professor Crosier.

The protein identified, known as RASIP1 (for Ras-interacting protein 1), was found to have a role in strengthening the connections between the cells that make up the blood vessels.

This discovery may open up a new opportunity to treat diseases in which blood vessels become very leaky, such as diabetic eye disease, sepsis and troublesome fluid accumulation around tumours. It may be possible to develop small molecules that can enhance the activity of RASIP1, which could be useful for the treatment of these disorders.

Explore further: Gene links obesity and immunity

Related Stories

Gene links obesity and immunity

August 16, 2013

Auckland scientists have discovered a gene that links the immune system with obesity and potentially a new pathway to fight the worldwide obesity epidemic.

Protein responsible for 'bad' blood vessel growth discovered

July 17, 2013

The discovery of a protein that encourages blood vessel growth, and especially 'bad' blood vessels – the kind that characterise diseases as diverse as cancer, age-related macular degeneration and rheumatoid arthritis – ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.